Patent Term Application for ADQUEY (dilfamilast), Patent No. 10,588,893 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-4457

Patent Term Application for ADQUEY (dilfamilast), Patent No. 10,588,893

Documents

Comments

Key Dates

Comment Period OpensApr 27, 2026

Type	Title	Posted	Comments	Status
Other	Letter from U. S. Patent and Trademark Office	Apr 27, 2026	--	--

CDER

Otsuka Pharmaceutical Co Ltd

Sughrue Mion PLLC

Patent Term Application for ADQUEY (dilfamilast)

Patent No 10588893

OPEN